Hearing Loss :: Gene responsible for common hearing loss identified for first time

A gene responsible for the single most common cause of hearing loss among white adults, otosclerosis, has been identified for the first time, a scientist told the annual conference of the European Society of Human Genetics in Nice, France. Melissa Thys, from the Department of Medical Genetics, University of Antwerp, Belgium, said that this finding may be a step towards new treatments for otosclerosis, which affects approximately one in 250 people.

Insomnia :: Study demonstrated ROZEREM (ramelteon) does not affect body sway

Two studies presented today demonstrated that ROZEREM did not affect body sway at peak plasma levels, nor did it impair middle-of-the-night balance, mobility or memory performance in patients who suffer from chronic insomnia. The results of the studies were presented at the 21st Annual Meeting of the Associated Professional Sleep Societies (APSS).

DNA :: Exploring the dark matter of the genome

“Junk DNA” is what biologists used to call heterochromatin, the highly repetitive, gene-poor DNA concentrated near the centromeres and telomeres of chromosomes. With the publication of version 5.1 of the genome of the fruit fly, Drosophila melanogaster, led by scientists at Lawrence Berkeley National Laboratory and their colleagues, the term “junk” will be heard less often. Heterochromatin, it appears, is crucial to genome maintenance and cell biology.

COPD :: Premature vascular and bone changes occur in COPD patients

Researchers in the United Kingdom have found that patients with COPD, or chronic obstructive pulmonary disease, have greater arterial stiffness. The researchers also found that those COPD patients with osteoporosis, a common complication of the respiratory disease, had even greater arterial stiffness. These premature signs of aging may explain why COPD patients are at greater risk for cardiovascular disease.

Meningitis :: Hot on the TRAIL of controlling inflammation in bacterial meningitis

In a study appearing online on June 14 in advance of publication in the July print issue of the Journal of Clinical Investigation, researchers at Charit?-Universit?tsmedizin Berlin report that the molecule known as TRAIL can limit excessive immune responses in bacterial meningitis, and as such may be of use to control inflammation of the spinal cord and brain, which causes brain cell death in this life-threatening disease.

Dr. Anil Singhal Homeopathic Doctor | Dr. Anil Singhal's Blog | Manan - My Memoir by Dr. Anil Singhal | Boger's Legacy | Organon of Medicine | Health Newstrack